Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1949 3
1950 2
1951 3
1952 1
1953 3
1954 5
1955 5
1956 3
1957 6
1958 6
1959 7
1960 4
1961 9
1962 5
1963 6
1964 7
1965 3
1966 4
1967 5
1968 3
1969 3
1970 8
1971 8
1972 5
1973 7
1974 10
1975 8
1976 15
1977 11
1978 8
1979 20
1980 10
1981 12
1982 7
1983 10
1984 13
1985 20
1986 10
1987 6
1988 17
1989 18
1990 18
1991 15
1992 11
1993 12
1994 22
1995 20
1996 32
1997 21
1998 19
1999 26
2000 26
2001 23
2002 27
2003 17
2004 35
2005 40
2006 51
2007 63
2008 58
2009 65
2010 60
2011 58
2012 51
2013 59
2014 79
2015 75
2016 95
2017 103
2018 93
2019 93
2020 114
2021 134
2022 152
2023 125
2024 115
2025 61

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,081 results

Results by year

Filters applied: . Clear all
Page 1
Vogt-Koyanagi-Harada disease.
Joye A, Suhler E. Joye A, et al. Curr Opin Ophthalmol. 2021 Nov 1;32(6):574-582. doi: 10.1097/ICU.0000000000000809. Curr Opin Ophthalmol. 2021. PMID: 34545845 Review.
PURPOSE OF REVIEW: Here, we provide an overview of Vogt-Koyanagi-Harada disease (VKH), including recent updates in our understanding of disease pathophysiology, classification and therapeutics. ...Multimodal imaging is indispensable in the initi …
PURPOSE OF REVIEW: Here, we provide an overview of Vogt-Koyanagi-Harada disease (VKH), including recent updates …
Vogt-Koyanagi-Harada disease.
O'Keefe GA, Rao NA. O'Keefe GA, et al. Surv Ophthalmol. 2017 Jan-Feb;62(1):1-25. doi: 10.1016/j.survophthal.2016.05.002. Epub 2016 May 27. Surv Ophthalmol. 2017. PMID: 27241814 Review.
Vogt-Koyanagi-Harada disease presents clinically in 4 different phases: prodromal, uveitic, convalescent, and recurrent, with extraocular manifestations including headache, meningismus, hearing loss, poliosis, and vitiligo, to varying degrees. ...Patie
Vogt-Koyanagi-Harada disease presents clinically in 4 different phases: prodromal, uveitic, convalescent, and re
Vogt-Koyanagi-Harada Disease.
Tugal-Tutkun I, Smit DP, Abu El-Asrar AM, Herbort CP Jr, Thorne JE. Tugal-Tutkun I, et al. Ocul Immunol Inflamm. 2024 May;32(4):363-366. doi: 10.1080/09273948.2024.2331401. Epub 2024 Apr 24. Ocul Immunol Inflamm. 2024. PMID: 38657222 No abstract available.
Classification Criteria for Vogt-Koyanagi-Harada Disease.
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug;228:205-211. doi: 10.1016/j.ajo.2021.03.036. Epub 2021 Apr 9. Am J Ophthalmol. 2021. PMID: 33845018 Free PMC article.
PURPOSE: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease. DESIGN: Machine learning of cases with VKH disease and 5 other panuveitides. ...
PURPOSE: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease. DESIGN: Machine learning o …
Vogt-Koyanagi-Harada disease.
Cunningham ET Jr, Rathinam SR, Tugal-Tutkun I, Muccioli C, Zierhut M. Cunningham ET Jr, et al. Ocul Immunol Inflamm. 2014 Aug;22(4):249-52. doi: 10.3109/09273948.2014.939530. Ocul Immunol Inflamm. 2014. PMID: 25014114 Review. No abstract available.
Vogt-Koyanagi-Harada disease.
Burkholder BM. Burkholder BM. Curr Opin Ophthalmol. 2015 Nov;26(6):506-11. doi: 10.1097/ICU.0000000000000206. Curr Opin Ophthalmol. 2015. PMID: 26448042 Review.
PURPOSE OF REVIEW: The purpose of this article is to review the current literature on Vogt-Koyanagi-Harada (VKH) disease, including current treatment options and new research directions. RECENT FINDINGS: Recent publications on VKH disease show a …
PURPOSE OF REVIEW: The purpose of this article is to review the current literature on Vogt-Koyanagi-Harada (VKH) dis
[Vogt-Koyanagi-Harada disease].
Bonnet C, Daudin JB, Monnet D, Brézin A. Bonnet C, et al. J Fr Ophtalmol. 2017 Jun;40(6):512-519. doi: 10.1016/j.jfo.2017.02.006. Epub 2017 Jun 1. J Fr Ophtalmol. 2017. PMID: 28579215 Review. French.
Vogt-Koyanagi-Harada (VKH) disease is defined as a severe bilateral, chronic granulomatous panuveitis associated with serous retinal detachments, disk edema, and vitritis, with central nervous system, auditory, and integumentary manifestations. It is a
Vogt-Koyanagi-Harada (VKH) disease is defined as a severe bilateral, chronic granulomatous panuveitis associated
Vogt-Koyanagi-Harada disease.
Street D, Sivaguru A, Sreekantam S, Mollan SP. Street D, et al. Pract Neurol. 2019 Aug;19(4):364-367. doi: 10.1136/practneurol-2018-002152. Epub 2019 Mar 19. Pract Neurol. 2019. PMID: 30890584
Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations, mediated through a T-helper 1 response against melanocytes in the eye, inner ear, central nervous system, hair and skin. ...Following treatm
Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations,
Vogt-Koyanagi-Harada disease.
Read RW, Rao NA, Cunningham ET. Read RW, et al. Curr Opin Ophthalmol. 2000 Dec;11(6):437-42. doi: 10.1097/00055735-200012000-00009. Curr Opin Ophthalmol. 2000. PMID: 11141638 Review.
Vogt-Koyanagi-Harada (VKH) disease affects primarily persons who are Asian, Latino, Native American, or Asian Indian. Women appear to be affected more commonly than men, and VKH disease may occur at all ages, including childhood. Experimental da
Vogt-Koyanagi-Harada (VKH) disease affects primarily persons who are Asian, Latino, Native American, or Asian In
Vogt-Koyanagi-Harada disease in Spain.
Arriola-Villalobos P, Moll-Udina A, Carrasco-López-Brea M, Sacristan C, Capella MJ, Peiteado D, Garrote-Llordén A, Albert Fort M, Jódar Márquez M, Jacobo Gonzalez Guijarro J, Demetrio-Pablo R, Luis Sánchez Sevilla J, Carreño E, González-López J, Miguel-Escuder L, Cuadros C, Díaz-Valle D, Adan A; Contributors: VKH Spanish Study Group; Benítez Del Castillo JM, Fonollosa A, Cordero M, Martínez Costa L, Blanco-Alonso R. Arriola-Villalobos P, et al. Eur J Ophthalmol. 2022 May;32(3):1547-1554. doi: 10.1177/11206721211033477. Epub 2021 Jul 16. Eur J Ophthalmol. 2022. PMID: 34269103
PURPOSE: To describe the clinical and epidemiological characteristics of patients with Vogt-Koyanagi-Harada (VKH) disease in Spain. METHODS: This was a retrospective multicenter analysis of data from VKH patients followed for at least 6 months. ...Ethn …
PURPOSE: To describe the clinical and epidemiological characteristics of patients with Vogt-Koyanagi-Harada (VKH) di
2,081 results